A resolution expressing the sense of the Senate that the operations of the National Institutes of Health should not experience any interruption, delay, or funding disruption in violation of the law and that the workforce of the National Institutes of Health is essential to sustaining medical progress.
S. Res. 93 is a sense-of-the-Senate resolution stating that the National Institutes of Health (NIH) should not face any interruption, delay, or funding disruption that would violate the law. It frames uninterrupted NIH operations as important to the health, economic vitality, and national security of the United States, and specifically highlights NIH-supported research on childhood cancers, Alzheimer’s disease, diabetes, heart disease, infectious diseases, amyotrophic lateral sclerosis (ALS), and other conditions.
The resolution also declares that the NIH workforce — including scientists, researchers, and medical professionals — is essential to sustaining medical progress. It says interference with that workforce would undermine the development of life-saving treatments, weaken the biomedical research enterprise, and threaten the nation’s ability to respond to public health challenges. As a resolution of sentiment, it does not itself create new regulatory requirements or appropriations, but it expresses the Senate’s position on protecting NIH operations and personnel.
The measure would not directly amend the U.S. Code or change NIH’s statutory authorities; instead, it expresses the Senate’s view that NIH operations and funding should continue without unlawful interruption. Its practical impact is primarily political and interpretive, signaling support for stable federal biomedical research funding and for the NIH workforce, while reinforcing opposition to shutdown-related or otherwise unlawful disruptions that could affect grants, intramural research, and agency operations.
The available context suggests strong supportive sentiment among the resolution’s sponsors, who are largely Senate Democrats and leadership figures. The text is framed as a defense of medical research, public health, and the NIH workforce, and there are no recorded votes or committee debate excerpts indicating opposition in the provided materials. Overall, the resolution appears to be a broadly pro-NIH statement intended to affirm continuity of operations and research funding.
No specific committee debate or vote history is provided, so no direct points of contention are documented in the record supplied. The likely area of disagreement, if any, would be the resolution’s implicit criticism of any interruption or funding disruption affecting NIH, especially in the context of federal budget or shutdown disputes. Any contention would center on federal spending priorities, agency funding stability, and the scope of executive or congressional actions that could affect NIH operations.